← Back to Search

Immunonutrition

Immunonutrition Supplements for Burns

N/A

Waitlist Available

Led By Alexandra Lacey, MD, RD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months

Awards & highlights

Study Summary

This trial will study the effects of immunonutrition supplements on burn wound healing in older patients.

Who is the study for?

This trial is for older adults aged 65 and above who have been hospitalized with thermal burns covering 5-15% of their body. They must understand the study and agree to participate. People can't join if they have inhalation injuries, severe liver or kidney disease, or are on immunosuppressive drugs like steroids.Check my eligibility

What is being tested?

The study tests whether special nutrition supplements (with arginine and omega-3 fatty acids) help heal burn wounds better than conventional supplements in older patients. Participants will be randomly assigned to one of two groups and followed for three months.See study design

What are the potential side effects?

Potential side effects may include allergic reactions to supplement ingredients, gastrointestinal discomfort such as nausea or diarrhea, and possible interactions with other medications.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Time to Complete Wound Closure

Secondary outcome measures

Incidence of Infections

Incidence of Surgical Grafting

Length of Inpatient Stay

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ImmunonutritionExperimental Treatment1 Intervention

Participants will consume a 6oz immunonutrition drink 2 times daily for 7 days and then once a day for remaining hospital stay.

Group II: Conventional SupplementActive Control1 Intervention

Participants will consume a 6oz conventional supplement drink 3 times daily for 7 days and then once a day for remaining hospital stay.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Impact Advanced Recovery

2019

Completed Phase 3

~470

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,182 Previous Clinical Trials

3,167,367 Total Patients Enrolled

2 Trials studying Burns

25 Patients Enrolled for Burns

Alexandra Lacey, MD, RDPrincipal InvestigatorUniversity of Wisconsin, Madison

Rebecca A Busch, MD, FACSPrincipal InvestigatorUniversity of Wisconsin, Madison

Media Library

Burns Clinical Trial 2023: Impact Advanced Recovery Highlights & Side Effects. Trial Name: NCT04725071 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research initiative currently available?

"Evidently, the clinical trial listed on clinicaltrials.gov does not have an open call for patients at this time; it was first posted on July 1st 2022 and last updated that same day. In spite of its inactive status, there are 808 other medical research studies actively recruiting participants presently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults

2022. "Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04725071.